Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Marksans Pharma Limited
MARKSANSMarksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, upper respiratory, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. It also produces a range of solid oral dosage forms, including tablets and hard gelatin capsules; soft gels; essential oils; ointments; and creams and liquids, as well as prescription drugs. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India. Address: Grandeur, Mumbai, India, 400053
Analytics
Objectif de Cours de WallStreet
2 617.34 INRRatio C/B
40.8144Rendement du dividende
0.2 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés MARKSANS
Analyse des dividendes MARKSANS
Croissance des dividendes sur 5 ans
900 %Croissance continue
1 annéeRatio de distribution Moyenne sur 5 ans
5 %Historique des dividendes MARKSANS
Valorisation des titres MARKSANS
financières MARKSANS
Résultats | 2019 | Dynamique |